Revelation of Immune Memory at the First Stage of Antigen-Specific Cell Response after Second Introduction of the Live Plague Vaccine

Background. The study of immune memory is necessary to evaluate the effectiveness of immunization against infection, including plague and to make a choice of vaccination scheme.

Goals. The goal is to study the possible role of immune memory in the early stage of the antigen-specific response – the formation of cells with receptors for capsular (F1) and lipopolysaccharide (LPS) antigens of plague live EV vaccine.

Methodology. Volunteers vaccinated with live plague vaccine EV for the first time (6 persons – group 1) and again (6 persons – group 2) were examined. In the mononuclear fraction of the blood of volunteers the cells binding antigens F1 and LPS Y. pestis (CBA) were determined.

Results. In the volunteers group 2, the content of CBA at 2 days after vaccination was higher than in group 1. Between the 5th day and the end of the CBA detection, their content in group 2 decreased, and in group 1, it increased, but remained significantly less than in group 2 two days after immunization.

Сonclusions. It is shown that the previous vaccination accelerates the first stage of the antigen-specific human response to second vaccination against plague. This reflects the role of immune memory in the formation of this stage of the immune response at vaccination against plague.

1. Petrov R.V., Chaitov R.M. Immunogens and vaccines of a new generation Moscow: «GEOTAR Media»; 2011 608 P. (In Russ.).

2. Karalnik B.V., Deryabin P.N., Denisova T.G., et al. Antigen-binding lymphocytes in the dynamics of the immune response to bacterial, viral and autoantigens. News of the Ministry of Education and Science of the Republic of Kazakhstan, National Academy of Sciences of the Republic of Kazakhstan. A biology and medicine series. 2001; (5): 37–43 (In Russ.).

3. Deryabin P., Ponomaryova T., Karalnik B., et al. Influence of human recombinant interleukin-1beta on protective and immunogenic efficacy of live plague vaccine. Medical and Health Science Journal. 2014; 15 (1): 27–34. doi: http://dx.doi.org/10.15208/mhsj.2014.04

4. Zunusova G.B., Karalnik B.V., Azizov D.A., et al. Antigen-binding lymphocytes of gonococcal specificity in immunized rabbits Hygiene, Epidemiology and Immunobiology. 2000; (3–4): 101–106 (In Russ.).

5. Deryabin P.N., Karalnik B.V., Denisova T.G., et al. Development of a reagent for assessing the initial stage of an immune response to live plague vaccine. Problems of especially dangerous infections. 2016; (2): 102–106 (In Russ.). doi: 10.21055/0370-1069-2016-2-102-106.

6. Li B, Du Ch, Zhou L et al. Humoral and cellular responses to Yersinia pestis infection in long-term recovered plague patients. Clinical Vaccinology Immunology. Current issue. 2017; 24 (5). Online21 December 2011. doi: 10.1128/CVI.o5559-11.

7. Parham P. Innate immunity: The unsung heroes. Nature. 423: (20 01 May 2003) Concepts Published 01 May 2003.

8. Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell. 2006; 124 (4): 849–863. http://dx.doi.org/10.1o16/j.cell.2006.02.019.

9. Levy O, Netea MG. Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines. Pediatric Researches. 2014; (75):184 188 doi:10.1038/pr.2013.214.

10. Netea MG, Latz E, Mills KHG et al. Innate immune memory: a paradigm shift in understanding host defense. Nature immunology. 2015; 16 (7): 675–679. https://doi.org/10.1038/ni.3178.

11. Mihai G, Netea MG, Leo AB et al. Trained immunity: A program of innate immune memory in health and disease. Science. 2016; 352 (Issue 6284): aaf1098. doi: 10.1126/science.aaf1098.

12. Janeway CA Jr The immune system evolved to discriminate infectious nonself from noninfectious self. Immunology today. 1992 v. 13 (Iissue 1): 11–16. https://doi.org/10.1016/0167-5699(92)90198-G.

13. Petrov R.V., Chaitov R.M. Immunogens and vaccines of a new generation Moscow: «GEOTAR Media»; 2011 (In Russ.).